Webdisclosure.fr

Search

UCB (EBR:UCB) UCB Media Room: Disposal of own shares

Directive transparence : information réglementée

23/09/2022 20:00
https://mb.cision.com/Public/18595/3635918/b92cf093d562c84f_800x800ar.png ** Disposal of own shares ------------------------------------------------------------ Brussels (Belgium), 23 September 2022 =E2=80=93 20:00 (CEST) =E2=80=93 Regu= lated information=C2=A0 In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB announces that, following exercises o= f stock options by members of its personnel, it has disposed of UCB shares = OTC in view of deliveries of these shares to the relevant members of the pe= rsonnel, within the framework of the Long-Term Incentive Program of the UCB= Group, as follows: https://mb.cision.com/Public/18595/3635918/94a83133193c39ab_800x800ar.png This press release is available on UCB SA/NV=E2=80=99s website via the foll= owing link (https://www.ucb.com/stories-media/Press-Releases) . For further information, contact UCB:=C2=A0 Investor Relations Antje Witte=C2=A0 T +32 2 559 94 14 antje.witte@ucb.com Corporate Communications Laurent Schots=C2=A0 T+32 2 559 92 64 laurent.schots@ucb.com =C2=A0=C2=A0 =C2=A0 About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company = focused on the discovery and development of innovative medicines and soluti= ons to transform the lives of people living with severe diseases of the imm= une system or of the central nervous system. With approximately 8 600 peopl= e in nearly 40 countries, the company generated revenue of =E2=82=AC 5.8 bi= llion in 2021. UCB is listed on Euronext Brussels (symbol: UCB). Follow us = on Twitter: @UCB_news =C2=A0 GenericFile 220923 - Vervreemding van eigen aandelen NL (https://mb.cision.com/Public/1= 8595/3635918/a068a9c3e71fe17a.pdf) GenericFile 220923 - Disposals of own shares ENG (https://mb.cision.com/Public/18595/36= 35918/8a913fc5a4649aac.pdf) GenericFile 220923- Ali=C3=A9nation d actions propres FR (https://mb.cision.com/Public/= 18595/3635918/937444b4c0bb17e8.pdf) Image Chart 1 Sept 23 2022 (https://mb.cision.com/Public/18595/3635918/94a8313319= 3c39ab_org.png) ______________________ If you would rather not receive future communications from UCB SA, please g= o to https://eu.vocuspr.com/OptOut.aspx?2973226x20421x116885x1x6868579x2400= 0x6&Email=3Dregnews%40symexglobal.com. UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium